Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized sequential therapy versus 10-day and 14-day concomitant therapy for Helicobacter pylori eradication
PACTR202112632957229Unknown
- Sponsor
- Mohamed V Military Teaching Hospital
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of amoxicillin, clarithromycin and metronidazole in Helicobacter pylori infection (3 arms), sponsored by Mohamed V Military Teaching Hospital. Primary endpoint: Helicobacter pylori eradication. Status: unknown.
02
Drugs
amoxicillinclarithromycinmetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on PACTR202112632957229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202112632957229.